CBP22, a Novel Bacteriocin Isolated from Clostridium butyricum ZJU-F1, Protects against LPS-Induced Intestinal Injury through Maintaining the Tight Junction Complex

A novel bacteriocin secreted by Clostridium butyricum ZJU-F1 was isolated using ammonium sulfate fractionation, cation exchange chromatography, affinity chromatography, and reverse-phase high-performance liquid chromatography (RP-HPLC). The bacteriocin, named CBP22, contained 22 amino acids with the...

Full description

Saved in:
Bibliographic Details
Main Authors: Tenghao Wang, Jie Fu, Xiao Xiao, Zeqing Lu, Fengqin Wang, Mingliang Jin, Yizhen Wang, Xin Zong
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2021/8032125
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565864033943552
author Tenghao Wang
Jie Fu
Xiao Xiao
Zeqing Lu
Fengqin Wang
Mingliang Jin
Yizhen Wang
Xin Zong
author_facet Tenghao Wang
Jie Fu
Xiao Xiao
Zeqing Lu
Fengqin Wang
Mingliang Jin
Yizhen Wang
Xin Zong
author_sort Tenghao Wang
collection DOAJ
description A novel bacteriocin secreted by Clostridium butyricum ZJU-F1 was isolated using ammonium sulfate fractionation, cation exchange chromatography, affinity chromatography, and reverse-phase high-performance liquid chromatography (RP-HPLC). The bacteriocin, named CBP22, contained 22 amino acids with the sequence PSAWQITKCAGSIAWALGSGIF. Analysis of its structure and physicochemical properties indicated that CBP22 had a molecular weight of 2264.63 Da and a +1 net charge. CBP22 showed activity against E. col K88, E. coli ATCC25922, and S. aureus ATCC26923. The effects and potential mechanisms of bacteriocin CBP22 on the innate immune response were investigated with a lipopolysaccharide- (LPS-) induced mouse model. The results showed that pretreatment with CBP22 prevented LPS-induced impairment in epithelial tissues and significantly reduced serum levels of IgG, IgA, IgM, TNF-α, and sIgA. Moreover, CBP22 treatment increased the expression of the zonula occludens and reduced permeability as well as apoptosis in the jejunum in LPS-treated mice. In summary, CBP22 inhibits the intestinal injury and prevents the gut barrier dysfunction induced by LPS, suggesting the potential use of CBP22 for treating intestinal damage.
format Article
id doaj-art-74af83f220a24d43801916c7c098c5c8
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-74af83f220a24d43801916c7c098c5c82025-02-03T01:06:16ZengWileyMediators of Inflammation0962-93511466-18612021-01-01202110.1155/2021/80321258032125CBP22, a Novel Bacteriocin Isolated from Clostridium butyricum ZJU-F1, Protects against LPS-Induced Intestinal Injury through Maintaining the Tight Junction ComplexTenghao Wang0Jie Fu1Xiao Xiao2Zeqing Lu3Fengqin Wang4Mingliang Jin5Yizhen Wang6Xin Zong7Key Laboratory of Molecular Animal Nutrition, Ministry of Education, College of Animal Sciences, Zhejiang University, Hangzhou, ChinaKey Laboratory of Molecular Animal Nutrition, Ministry of Education, College of Animal Sciences, Zhejiang University, Hangzhou, ChinaKey Laboratory of Molecular Animal Nutrition, Ministry of Education, College of Animal Sciences, Zhejiang University, Hangzhou, ChinaKey Laboratory of Molecular Animal Nutrition, Ministry of Education, College of Animal Sciences, Zhejiang University, Hangzhou, ChinaKey Laboratory of Molecular Animal Nutrition, Ministry of Education, College of Animal Sciences, Zhejiang University, Hangzhou, ChinaKey Laboratory of Molecular Animal Nutrition, Ministry of Education, College of Animal Sciences, Zhejiang University, Hangzhou, ChinaKey Laboratory of Molecular Animal Nutrition, Ministry of Education, College of Animal Sciences, Zhejiang University, Hangzhou, ChinaKey Laboratory of Molecular Animal Nutrition, Ministry of Education, College of Animal Sciences, Zhejiang University, Hangzhou, ChinaA novel bacteriocin secreted by Clostridium butyricum ZJU-F1 was isolated using ammonium sulfate fractionation, cation exchange chromatography, affinity chromatography, and reverse-phase high-performance liquid chromatography (RP-HPLC). The bacteriocin, named CBP22, contained 22 amino acids with the sequence PSAWQITKCAGSIAWALGSGIF. Analysis of its structure and physicochemical properties indicated that CBP22 had a molecular weight of 2264.63 Da and a +1 net charge. CBP22 showed activity against E. col K88, E. coli ATCC25922, and S. aureus ATCC26923. The effects and potential mechanisms of bacteriocin CBP22 on the innate immune response were investigated with a lipopolysaccharide- (LPS-) induced mouse model. The results showed that pretreatment with CBP22 prevented LPS-induced impairment in epithelial tissues and significantly reduced serum levels of IgG, IgA, IgM, TNF-α, and sIgA. Moreover, CBP22 treatment increased the expression of the zonula occludens and reduced permeability as well as apoptosis in the jejunum in LPS-treated mice. In summary, CBP22 inhibits the intestinal injury and prevents the gut barrier dysfunction induced by LPS, suggesting the potential use of CBP22 for treating intestinal damage.http://dx.doi.org/10.1155/2021/8032125
spellingShingle Tenghao Wang
Jie Fu
Xiao Xiao
Zeqing Lu
Fengqin Wang
Mingliang Jin
Yizhen Wang
Xin Zong
CBP22, a Novel Bacteriocin Isolated from Clostridium butyricum ZJU-F1, Protects against LPS-Induced Intestinal Injury through Maintaining the Tight Junction Complex
Mediators of Inflammation
title CBP22, a Novel Bacteriocin Isolated from Clostridium butyricum ZJU-F1, Protects against LPS-Induced Intestinal Injury through Maintaining the Tight Junction Complex
title_full CBP22, a Novel Bacteriocin Isolated from Clostridium butyricum ZJU-F1, Protects against LPS-Induced Intestinal Injury through Maintaining the Tight Junction Complex
title_fullStr CBP22, a Novel Bacteriocin Isolated from Clostridium butyricum ZJU-F1, Protects against LPS-Induced Intestinal Injury through Maintaining the Tight Junction Complex
title_full_unstemmed CBP22, a Novel Bacteriocin Isolated from Clostridium butyricum ZJU-F1, Protects against LPS-Induced Intestinal Injury through Maintaining the Tight Junction Complex
title_short CBP22, a Novel Bacteriocin Isolated from Clostridium butyricum ZJU-F1, Protects against LPS-Induced Intestinal Injury through Maintaining the Tight Junction Complex
title_sort cbp22 a novel bacteriocin isolated from clostridium butyricum zju f1 protects against lps induced intestinal injury through maintaining the tight junction complex
url http://dx.doi.org/10.1155/2021/8032125
work_keys_str_mv AT tenghaowang cbp22anovelbacteriocinisolatedfromclostridiumbutyricumzjuf1protectsagainstlpsinducedintestinalinjurythroughmaintainingthetightjunctioncomplex
AT jiefu cbp22anovelbacteriocinisolatedfromclostridiumbutyricumzjuf1protectsagainstlpsinducedintestinalinjurythroughmaintainingthetightjunctioncomplex
AT xiaoxiao cbp22anovelbacteriocinisolatedfromclostridiumbutyricumzjuf1protectsagainstlpsinducedintestinalinjurythroughmaintainingthetightjunctioncomplex
AT zeqinglu cbp22anovelbacteriocinisolatedfromclostridiumbutyricumzjuf1protectsagainstlpsinducedintestinalinjurythroughmaintainingthetightjunctioncomplex
AT fengqinwang cbp22anovelbacteriocinisolatedfromclostridiumbutyricumzjuf1protectsagainstlpsinducedintestinalinjurythroughmaintainingthetightjunctioncomplex
AT mingliangjin cbp22anovelbacteriocinisolatedfromclostridiumbutyricumzjuf1protectsagainstlpsinducedintestinalinjurythroughmaintainingthetightjunctioncomplex
AT yizhenwang cbp22anovelbacteriocinisolatedfromclostridiumbutyricumzjuf1protectsagainstlpsinducedintestinalinjurythroughmaintainingthetightjunctioncomplex
AT xinzong cbp22anovelbacteriocinisolatedfromclostridiumbutyricumzjuf1protectsagainstlpsinducedintestinalinjurythroughmaintainingthetightjunctioncomplex